A services firm in the Midlands had been running its CRM’s built-in AI assistant for six months when the vendor shipped a platform update. The assistant started categorising leads differently and routing follow-ups to the wrong people. No automated check caught it. By the time the pattern appeared in a monthly pipeline review, three weeks of incorrect lead handling had already run through the business. The question the team asked afterwards was a practical one: which tools would have made it realistic to catch that before it caused damage?
What choice are you actually facing?
The choice looks like a software decision: a testing tool, a QA budget line. What it actually comes down to is how much engineering time your team can spend keeping test scripts aligned with a front-end that changes whenever your AI vendor ships an update. AI-native platforms claim to auto-resolve around 95% of UI changes automatically. Open-source frameworks put that maintenance work on your developers.
Business AI systems create a regression testing problem that traditional QA tooling was not designed for. Classic suites check whether a button still works or a form still submits. AI systems can return different outputs from identical inputs as prompts, models, and underlying data pipelines evolve. Your test coverage needs to span two layers: the interface layer, where the AI feature lives inside a web app or CRM, and the behaviour layer, where outputs need to remain consistent with what your business expects.
The interface layer tool generally falls into one of three categories: an AI-native platform with self-healing locators (Virtuoso QA, Applitools, Functionize), a traditional framework like Selenium or Playwright, or a specialist ERP regression tool like Opkey or Tricentis Tosca if your AI features sit inside a packaged system such as SAP or Salesforce. The behaviour layer is a simpler and often cheaper question: API-level tests against your AI service that check outputs against a defined baseline.
When does an AI-native regression tool make sense?
AI-native regression platforms are built for front-ends that change often. If your business runs chat-style AI widgets, dynamic recommendation panels, or AI-assisted workflows that your vendor iterates on frequently, traditional scripts will break constantly as selectors and page structures shift. A self-healing engine reduces the effort of keeping those scripts current, which matters on a small team without dedicated automation engineers.
Virtuoso QA reports that its self-healing engine handles around 95% of UI and locator changes without manual intervention. Applitools uses a visual AI engine that compares rendered screenshots rather than relying on DOM selectors, making it more resilient to front-end restructuring. These are vendor claims, and no independent large-scale study has validated them across UK SME deployments, but the underlying principle is practical: if your AI features are visually volatile, you need tooling that keeps up.
For firms using AI features inside enterprise systems, Opkey and Tricentis Tosca offer test impact analysis that focuses regression effort on what changed, rather than re-running the full suite after every vendor release. That is a meaningful saving when the bulk of a business workflow is unaffected by any given update.
There is also a regulatory angle. The EU AI Act (2024) classes several common business uses, including creditworthiness assessment, employee evaluation, and certain recruitment tools, as high-risk, requiring documented testing and post-market monitoring. The ICO’s AI guidance reinforces this: organisations must test AI systems for accuracy, fairness, and reliability across the system lifecycle, not just at the point of deployment. A regression suite that runs automatically on every deployment is easier to evidence in an audit than a manual spot-check process.
When is a traditional framework still the right fit?
Selenium and Playwright are open-source, widely supported in CI/CD pipelines, and cost nothing to license. If your team already knows how to maintain code-based test suites and the AI features you’re testing sit inside a stable internal interface, the overhead of an AI-native platform may outweigh its benefits. The self-healing claims are vendor-generated; no large-scale independent study has validated them against real SME deployments.
Traditional frameworks make sense in several situations. If your UI is stable and your AI features are narrow, a well-written Playwright suite covers regression without the licence cost. If your team has existing automation skills and a standard CI/CD setup, the integration effort is low. If you are using a single vendor’s chat API for internal back-office tasks with limited customer impact, API-level regression tests may cover the ground without any UI layer. And where your AI component is off-the-shelf, the vendor’s own release notes and certification documentation carry part of the quality assurance burden.
Playwright has been closing the capability gap with commercial tools, adding code generation, trace viewers, and improved browser coverage. A peer-reviewed study at ICSE 2020 mapped the state of ML testing and found that while AI-based systems require different testing techniques from classical software, the interface layer remains testable with conventional methods where outputs are inspectable and behaviour is deterministic enough to assert against. That finding holds for many AI features in SME contexts.
What does it cost to get this wrong?
A gap in your regression testing is a business risk as much as a technical one. The EU AI Act classes several common business uses, including creditworthiness and certain recruitment tools, as high-risk, requiring documented testing and post-market monitoring. The ICO took a 2023 enforcement action against Snap over its AI chatbot’s failure to assess risk to children, and previously reprimanded the Department for Education over automated decision systems deployed without proper governance.
The Court of Appeal’s 2021 judgment in the Post Office Horizon case is routinely cited by UK regulators as a warning about systems relied upon for high-stakes decisions without adequate testing and challenge. For SMEs supplying services to regulated financial firms, the FCA’s AI and machine learning discussion paper sets expectations for model risk management that increasingly form the standard against which supplier processes are assessed. An undocumented or dormant test suite is unlikely to satisfy that standard.
The operational cost is harder to quantify but equally real. Undetected AI output drift, the kind the Midlands firm experienced with its CRM assistant, compounds across weeks. By the time it appears in a manual review, the business damage is already in the data.
What should you ask before you commit?
The tool you pick will sit inside your development workflow for years. The questions worth asking before committing fall into three areas: where your data goes, what it costs to leave, and whether the vendor’s reliability claims hold up outside their own marketing. Getting these answers in writing before signing a contract takes an hour; unwinding a poorly chosen dependency can take months.
On data and compliance: ask where the tool is hosted and whether that triggers UK GDPR international transfer requirements. Ask whether the vendor trains their models on your test data. The ICO’s anonymisation guidance is clear that test datasets should avoid identifiable personal data where possible; if your regression tests run against realistic customer scenarios, confirm how the tool handles that data before it leaves your network.
On security: ask for current certifications (ISO 27001 or SOC 2 Type II as a baseline) and how the vendor aligns with NCSC cloud security principles. For tools that process test artefacts outside your infrastructure, check what access controls, logging, and incident response commitments the contract includes.
On lock-in and interoperability: the CMA’s 2023 foundation models review set out principles for switching ability in AI-dependent tools. For regression testing, that translates to a practical question: can you export your test scripts and results if you move platform? Does the tool support your existing CI/CD pipeline, whether that is GitHub Actions, Jenkins, or Azure DevOps? A tool that only runs inside its own environment creates a dependency that becomes expensive if pricing changes or the product stalls.
The firms that handle this well start with a map of where AI features touch customer outcomes, where vendor updates are most frequent, and where a missed regression would cost real money or raise a compliance flag. That map tells you whether a self-healing platform is worth the spend, or whether a well-maintained open-source suite covers the ground you actually need. If you’d like to think through which layer applies to your business, Book a conversation.
